APOTEA.ST
APOTEA.ST
SE0023313762
Apotea AB
Loading chart...

Company Profile

Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, baby, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food and drink, mouth and teeth, premium, trip, sex and lust, stop smoking, makeup, sun protection, wounds and injuries, sleep and sleep problems, training, weight control, vitamins and minerals, charity, and eyes and ears. In addition, the company offers leasing and hiring out personnel to related companies, as well as marketing contributions. The company was founded in 2011 and is headquartered in Stockholm, Sweden.

Related stocks

DOCM.SW
DOCM.SW • Switzerland
DOCMORRIS N
13.32 CHF
818.16M USD 1Y +119.6%
RDC.DE
RDC.DE • Netherlands
Redcare Pharmacy N.V. A
72 EUR
1.62B USD 1Y -15.9%
002727.SZ
002727.SZ • China
YIXINTANG
10.99 CNY
963.01M USD 1Y -20.9%
PGMN3.SA
PGMN3.SA • Brazil
PAGUE MENOS ON NM
5.5 BRL
792.05M USD 1Y +53.2%
4163.SR
4163.SR • Saudi Arabia
Aldawaa Medical Services Co.
34.7 SAR
785.49M USD 1Y -48.4%
MEDPLUS.NS
MEDPLUS.NS • India
MEDPLUS HEALTH SERV LTD
625.3 INR
775.89M USD 1Y -17.2%
9267.T
9267.T • Japan
GENKY DRUGSTORES CO LTD
3,455 JPY
666.18M USD 1Y -29%
9627.T
9627.T • Japan
AIN HOLDINGS INC
5,423 JPY
1.21B USD 1Y -19.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
-
Max Drawdown (3Y)
-
Sharpe Ratio (3Y)
-
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
ende